Search

everythinglearnresearchcommunity

for

Search:↓

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

FDA-approved medications are important for treating high blood pressure in children, but non-approved ones can be used if needed.

Acitretin effectively treats severe hypertrophic lichen planus.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Upadacitinib may cause hair loss.

The document's conclusion cannot be determined without content.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

High-flux hemodialysis with L-carnitine improves heart function, reduces inflammation, and enhances quality of life in patients.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Baricitinib improved hair loss and arthritis in a lupus patient.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Taking dutasteride every other day works as well as daily and better preserves sexual function.

Baricitinib may not always prevent relapse in alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

Vasodilators may worsen abdominal aortic aneurysm.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Dutasteride reduces DHT more effectively than finasteride.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.